News

Fierce Pharma46m
Facing added pressure from Eli Lilly, Novo Nordisk submits for FDA approval of oral GLP-1 obesity drug
Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...
Fierce Pharma3h
Leo pads case for chronic hand eczema nod with survey showing overwhelming effects on patient lives
More than 90% of dermatology clinicians surveyed by Leo Pharma say their patients with moderate to severe chronic hand eczema ...
Fierce Pharma22h
Top leaders at FDA marketing overseer resign, potentially teeing up RFK Jr.’s promised drug ad ban: report
The two highest-ranking leaders within the FDA’s Office of Prescription Drug Promotion (OPDP) have stepped down, according to ...
Fierce Pharma22h
Gilead's Trodelvy-Keytruda proposal hits goal in first-line triple-negative breast cancer
In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in ...
Fierce Pharma23h
AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line breast cancer
AstraZeneca and Daiichi Sankyo are aiming to establish their star antibody-drug conjugate (ADC) Enhertu as a first-line ...
Fierce Pharma22h
Meribel makes CDMO debut after series of acquisitions in Europe
For a second time in less than a month, a new CDMO has uncloaked.  | For a second time in less than a month, a new CDMO has ...
Fierce Pharma23h
Amneal recalls 2 lots of hospital anesthetic over plastic contamination fears
Particulate contamination has sparked the recalls of numerous injectable drugs over the years, with Amneal’s hospital med ...